Liquid Biopsy Market - Current Trends, Opportunities and Forecast Liquid Biopsy Market- Current Trends, Opportunitie
According to the report “Global Liquid Biopsy Market" published by Market Data Forecast,
the global market is projected to reach USD 1.75 billion by 2021 from USD 590.2 million in
2016, at a CAGR of 24.3%.
Liquid Biopsy is a test done on a sample of blood to look for cancer cells from a tumour that
are circulating in the blood or for pieces of DNA from tumour cells that are in the blood. A
liquid biopsy may be used to help find cancer at an early stage. It may also be used to help
plan treatment or to find out how well treatment is working or if cancer has come back.
Being able to take multiple samples of blood over time may also help doctors understand
what kind of molecular changes are taking place in a tumour.
Request Free Sample: http://www.marketdataforecast.com/market-reports/global-liquid-
biopsy-market-950/request-sample
The factors influencing the Global Market for Liquid Biopsy Market, either positively or
negatively are presented in the DROC analysis. Liquid biopsies are adopted due to the
factors such as tolerability and patient convenience. Tissue biopsies cannot be done for few
non-small cell lung cancers and liquid biopsy procedures are replacing tissue diagnosis
procedures in such cases. Liquid biopsy research process involves a large amount of money
and frequent clinical trials which is acting as a restraint for the market growth.
Customize Report: http://www.marketdataforecast.com/market-reports/global-liquid-
biopsy-market-950/customize-report
For granular level understanding, the Liquid Biopsy Market is segmented based on the
following categories with Market Size Estimations and Y-o-Y Forecasts presented for each
sub-segments.
By Cancer Type
Lung Cancer
Pancreatic Cancer
Leukemia
Other Visceral Cancers
By Sample Type
Blood
Urine
Plasma
Saliva
Cerebrospinal
By Diagnostic Approach
Circulating Tumour cells (CTC)
Circulating Tumour DNA (ctDNA)
RNA in exosomes
Extra-Cellular Vesicles